Medication Management

Review of evidence-based, person-centered strategies for improving patient comfort during IUD placements, from paracervical blocks to non-medication supports

Double dosing UPA for EC not needed for BMI > 30, postpartum implant placement and milk supply, mifepristone to increase efficacy of medication management of EPL.

Clinical guidance on early pregnancy loss and SMA, safety of outpatient abortion for people with higher body weights, and how to document first-trimester ultrasound findings.

Answers for healthcare providers on routes of misoprostol administration and what they mean for medication abortion care.

LNG-IUD and the risk of gynecologic and breast cancers, contraception and body weight, and preferred ways to get hormonal birth control.

Factors that increase risk for deep or nonpalpable implant, 12-hour vs. 24-hour mifepristone-misoprostol interval, and two studies reinforcing the safety and efficacy of no-test medication abortion.

What providers need to know about the December 2022 updates to levonorgestrel emergency contraception (LNG-EC) labeling.

Usage of combined oral contraceptives to manage PMS and PMDD symptoms, surgical abortion pain management for patients with opioid use disorder, risks associated with post-placental IUD placement, and more.